Popular diabetes and weight-loss drug may reduce risk of Alzheimer’s disease Post author: Post published:October 24, 2024 Post category:News Feed Post comments:0 Comments Researchers have found that semaglutide may lower the risk of Alzheimer’s disease in people with type 2 diabetes (T2D). You Might Also Like Blood test distinguishes neuroendocrine subtype of advanced prostate cancer January 11, 2024 Ultrasound-directed microbubbles could boost immune response against tumors January 16, 2025 Nasal microbiota is potential diagnostic biomarker for sepsis June 12, 2024 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.